Key facts
- This page summarizes Martha Shadan's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Mar 2026, 21:16.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 1/3 upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next two years.
Footnote F2
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
Footnote F3
These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.